際際滷

際際滷Share a Scribd company logo
NCCU Journal Club

  JOSHUA KORNBLUTH, MD
       F E B 5 TH, 2 0 1 3
 Objective: to review a recent randomized trial of
  intracranial pressure monitoring in sTBI
 To encourage thought and discussion of our own
  practices
 To consider future directions


 Nothing for me to disclose
Study Overview

 Does intracranial pressure monitoring improve
  outcomes in severe TBI?
 What is the current standard of care in America?
 Why does this question matter?


 Multicenter, 324 adult pts, severe TBI, randomized
  to two separate protocols
 Looked at in-hospital events, survival time and 3-
  and 6- month outcomes
Nccu journal club 2.5.13
You heard it from the BTF
Study Overview

 Can we conduct this type of study in America?
 Highly unlikely, so let's take advantage of alternative
  standards of care to investigate.
 Study Design
    Multicenter, parallel-group trial
    Random assignment to ICP-monitoring group vs imaging-
     clinical examination group
    Study started in Bolivian hospitals, and additional hospitals
     were added later to increase enrollment
Study Design  Inclusion Criteria

 Traumatic brain injury
 GCS < 8 on admission or within first 48 hours after
    injury (Motor score  5 if intubated)
   Admission to study hospital within 24 hours of injury
   No foreign object in the brain parenchyma.
   Age > 12
   Randomized:
       within 24 hours of injury [for patients with GCS < 8 on admission] or
       within 24 hours of deterioration [patients deteriorating to GCS < 8
        within 48 hours of injury
 Randomization stratified according to site, injury
    severity score, and age
Study Design  Exclusion Criteria

 GCS of 3 with bilateral fixed and dilated pupils
 No consent
 Pregnant
 Prisoner
 No beds available in ICU
 No ICP monitor available
 Non-survivable injury
 Other (e.g., Pre-injury life expectancy under 1 year)
 Pre-existing neurological disability that would
 confound outcome
Study Design - protocol

 Place patient on mechanical ventilation (VM)
 Place continuous SaPO2 and EtCO2 monitors
 Insert indwelling urinary catheter to monitor urine output
 Insert arterial catheter for arterial mean pressure monitoring
 Insert central venous catheter for infusion of solutions and
  central venous pressure monitoring.
 Monitor neurological clinical status each hour
     Pupils
     GCS
 Brain CT
   To evaluate evolution 48 hours after the admission CT
   To evaluate evolution 5-7 days after the admission CT
   p.r.n.
Study Design  Standards of Critical Care

                       Clearly delineate standard basic Critical Care

 Head positioning 30尊
 Head and neck in neutral position and aligned
 Avoid hyperthermia (Defined as central temperature > 38 尊 C)
   Non-drug measures (cooling)
   Dipirona (Metamizole sodium)
 Early enteral nutritional support
   Before 48 hours
   25 Kcal/kg weight
 Pharmacologic prophylactic of post traumatic seizures (Phenytoin (IV or PO))
   Load and maintenance dose as is being giving in each hospital
 Gastric bleeding prophylaxis
   Ranitidine or Omeprazol
 Avoid decubitus lesions
 Deep venous thrombosis prophylaxis
 Frequent tracheal suctioning with sterile technique to prevent pulmonary infections
Study Design  ICP group

 Had parenchymal monitor ASAP (i.e. after
    randomization and resolution of coagulopathy if
    present)
   Position was not specified
   Treat if ICP20mmHg x 5min
   If CSF drainage indicated, EVD placed
   CPP goal 50-70mmHg
Study Design  Treatments (ICP Group)

 Treatments based on a Therapeutic Intensity Level
 If signs of intracranial HTN, clinical or imaging
   1  hyperosmolar therapy (mannitol)
        5% NaCl only if hypotenisve, hypovolemic, hyponatremic
    2  optional mild hyperventilation (pCO2 30-35mmHg)
    3  Ventricular drainage if possible*
Study Design  Definitions (ICP Group)

 Intracranial Pressure Definitions:
   Treatable intracranial hypertension:
         ICP > 20 mmHg for > 5 minutes
     Treatment failure:
       ICP not reduced to  20 mmHg within 20 minutes after a
        treatment intervention is initiated, and
       Persistent elevation in ICP > 20 mmHg requires increase in
        therapeutic intensity level
Study Design  Neuroworsening

 Neuroworsening = Incd TIL
   1. Decrease in the motor GCS > 2

   2. New loss of pupil reactivity

   3. Interval development of pupil asymmetry of > 2mm

   4. New focal motor deficit

   5. Herniation syndrome

 Give mannitol 0.25-1mg/kg to sOSM<320
 Hyperventilate to pCO2 25-30
 If no response  thiopental x 3d
 Craniectomy for space-occupying lesions
Study Design  Imaging only Group

 After optimized sedation and analgesia,
 hyperventilation and hyperosmotic therapy
 should be started simultaneously if there is
 evidence of edema on CT, as indicated as
 following:
    1. Compressed peri-mesencephalic cisterns
    2. Midline shift
    3. Cortical sulcal compression / effacement

 Otherwise, same metrics and goals of ICP
  monitored group
 Corticosteriods prohibited
 AEDs for prophylaxis >28d
Study Design - Outcomes

 Primary outcome  21-point composite of survival,
  duration and level of impaired consciousness, 3-
  month GOSe and GOAT, 6-month GOSe and
  neuropsych testing
 Secondary Outcomes  ICU LOS, number of days
  that patients received at least 1 brain-specific
  treatment, days of MV, treatment with high-dose
  barbiturates, decompressive crani
Results
Results - Demographics
Results

 MVAs accounted for most injuries (51% of
  randomized pts)
 45% of pts were brought in by ambulance
 Remainder were transferred from other facilities
 Did not publish pre-hospital demographics or
  interventions as these we not uniformly recorded
Results - Demographics

 24% of randomized patients had clinical decline to
  GCS within eligibility criteria
 49% of patients had localizing signs on clinical exam
 33% of participants required surgical treatment of
  mass lesions
 On initial CT, 85% had cisternal compression and
  36% had >5mm midline shift
Results  Clinical Outomes
HR for death at 6mos =1.10,
slightly in favor of ICP group
Nccu journal club 2.5.13
Nccu journal club 2.5.13
Results  Subgroup Analysis

 Hospital LOS was slightly shorter in the ICE group (iqr 12 for
  ICP, 9 for ICE)
 No significant differences in MV days, of non-neurologic
  complications
     Except ICP-monitored pts had a higher incidence of decubitus ulcers
      (12%vs 5%, P=0.03)
 Median time of ICP monitoring was 3.6d
 Incidence of Neuroworsening after randomization was 25% in
  the entire study, and was similar in both groups
 Median interval for brain-specific treatments was longer in
  ICE group
 Use of barbiturates was significantly higher in the ICP group
  (24% vs 13%)
 HTS and HV were used more in the ICE group (72% vs 58%,
  73% vs 60%)
Results

 Almost every variable, including LOS, mortality, anf
  functional outcomes favored ICP monitoring with a
  HR>1.
 The study was powered to detect statistical
  significance of HR>1.5
 Subgroup analysis of HR accounting for Marshall CT
  Classification
Results Summary

 Composite endpoints between the two groups were
 similar (P=0.49)
    ICP group = 56
    ICE group = 53
 Mortality at 6 months (P=0.06)
   ICP group=39%

   ICE group=41%

 ICE group had more days of brain specific
 treatments (hyperosmolar therapy, HV)
Discussion

 So what did the trial show?
 Clinicians act on ICP, without clinical correlate as
  evidenced by the increased use of barbiturates
 Clinicians also act on clinical findings without
  quantitative evidence of intracranial hypertension as
  evidenced by more brain-specific treatments overall
  in the ICE group.
 Is this because increased ICP could herald clinical
  changes and early interventions abort herniation
  events?
 Also, radiographic signs may not translate to the
  parenchymal monitor.
Discussion - Skepticism

 South America  differences in pre-hospital, and post-
    hospital care
   Less might survive to hospital or to hospital transfer
   Rehabilitation standards are different and may not
    translate to the same cognitive recovery
   35%death in all groups after 14d
   Adjusted estimates of sTBI mortality in the US varies
    from 41%-25% (J Neurotrauma. 2012 Jan 1;29(1):47-52., J Neurotrauma. 2012 Jan
    1;29(1):47-52.)
 The Thereapeutic Intensity Level is a good overall
    metric but others such as %responders to ICP-lowering
    therapy has proven predictive and should have been
    incorporated (J Neurosurg. 2011 May;114(5):1471-8)
Discussion - Skepticism

 Technology  parenchymal monitors as standard
 Triggers for treatment?  ICP>20 x 5 min vs
  radiographic signs with or without clinical correlates
 ICP group  ICP triggers  ICP is too simplistic a
  reflection of intracranial pathophysiology. No
  account for CPP
 Clinical signs dont always reflect global pressures
  and vice versa
 No discussion of inclusion/exclusion of polytrauma
  and surgical interventions
Discussion - Skepticism

 Variability in treatments (i.e. more mannitol and HV
  in the ICE group) may be because the ICE group had
  scheduled scans and interventions and the ICP group
  had more event-related treatment triggers
 Conversely, that may explain why the ICP group had
  more barbiturates and HTS
Discussion - benefits

 Very rigorous treatment algorithm for management
    of elevated ICP (either qualitative or quantitative)
   Homogenous population across countries
   Both groups had intracranial HTN treated that
    isnt in question
   In truth, this study did not test ICP monitoring, only
    a very specific treatment algorithm to an ICP
    threshold compared with clinical exam
   In the end, the neurologic exam might STILL be the
    best tool in our disposal.
Further Discussion

 This was probably the only way that this type of trial
  could be done
 Authors were careful not to compare South American
  patients to our own, only report their findings
 The goal of therapies was to lower the average ICP
  within the head  this doesnt accurately reflect
  mechanical compression and injury to diepnephalic
  which may portend a worse prognosis. The clinical
  signs of elevated ICP (pupil dilations, posturing,
  coma) are directly related to these areas.
Further Discussion

 How would you alter the study?
 Could multimodal monitoring be the next step?
 Are composite endpoints more useful that single
  variable? i.e. mortality? Return to work?
 Is a 6-month outcome long enough?


 Dont forget that even the most rigorous study
 cannot account for all possible variables and that this
 data might not apply to every patient.

More Related Content

What's hot (18)

Evolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic StrokeEvolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic Stroke
Pramod Krishnan
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
MedicineAndHealth
Does ICP monitoring in TBI really help? by Dr Paul Goldrick
Does ICP monitoring in TBI really help? by Dr Paul GoldrickDoes ICP monitoring in TBI really help? by Dr Paul Goldrick
Does ICP monitoring in TBI really help? by Dr Paul Goldrick
CICM 2019 Annual Scientific Meeting
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
CICM 2019 Annual Scientific Meeting
International Journal of Clinical Cardiology & Research
International Journal of Clinical Cardiology & ResearchInternational Journal of Clinical Cardiology & Research
International Journal of Clinical Cardiology & Research
SciRes Literature LLC. | Open Access Journals
Decompressive craniectomy final
Decompressive craniectomy   finalDecompressive craniectomy   final
Decompressive craniectomy final
Khaled Abdeen
Dexamethasone trial in chronic subdural hematoma
Dexamethasone trial in chronic subdural hematomaDexamethasone trial in chronic subdural hematoma
Dexamethasone trial in chronic subdural hematoma
Sandesh Dahal
Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?
Prisma Health Upstate
Ppt dawn trial
Ppt dawn trialPpt dawn trial
Ppt dawn trial
NeurologyKota
Journal Review
Journal Review Journal Review
Journal Review
NeurologyKota
Three New Trials in Stroke
Three New Trials in StrokeThree New Trials in Stroke
Three New Trials in Stroke
Dr Pradip Mate
Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015
Jon Sweet
Contemporary management of spinal injury by Dr Jonathon Ball
Contemporary management of spinal injury by Dr Jonathon BallContemporary management of spinal injury by Dr Jonathon Ball
Contemporary management of spinal injury by Dr Jonathon Ball
CICM 2019 Annual Scientific Meeting
Thrombectomy in Stroke: DAWN and DEFUSE3 trial data
Thrombectomy in Stroke: DAWN and DEFUSE3 trial dataThrombectomy in Stroke: DAWN and DEFUSE3 trial data
Thrombectomy in Stroke: DAWN and DEFUSE3 trial data
SCGH ED CME
Elma mg out 2 jurnal
Elma mg out 2 jurnalElma mg out 2 jurnal
Elma mg out 2 jurnal
MaharaniElma
Ihast pp
Ihast ppIhast pp
Ihast pp
MQ_Library
Acupuncture for patients_with_migraine_rct
Acupuncture for patients_with_migraine_rctAcupuncture for patients_with_migraine_rct
Acupuncture for patients_with_migraine_rct
Instituto de Psicobiof鱈sica Rama Schain
Decreased door to balloon time
Decreased door to balloon timeDecreased door to balloon time
Decreased door to balloon time
DrShamshad Khan
Evolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic StrokeEvolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic Stroke
Pramod Krishnan
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
SURVEY OF TURKISH PRACTICE EVALUATING THE MANAGEMENT OF POSTDURAL PUNCTURE HE...
MedicineAndHealth
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
Lifting the lid on decompressive craniectomy by Associate Professor Lindy Jef...
CICM 2019 Annual Scientific Meeting
Decompressive craniectomy final
Decompressive craniectomy   finalDecompressive craniectomy   final
Decompressive craniectomy final
Khaled Abdeen
Dexamethasone trial in chronic subdural hematoma
Dexamethasone trial in chronic subdural hematomaDexamethasone trial in chronic subdural hematoma
Dexamethasone trial in chronic subdural hematoma
Sandesh Dahal
Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?
Prisma Health Upstate
Three New Trials in Stroke
Three New Trials in StrokeThree New Trials in Stroke
Three New Trials in Stroke
Dr Pradip Mate
Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015
Jon Sweet
Thrombectomy in Stroke: DAWN and DEFUSE3 trial data
Thrombectomy in Stroke: DAWN and DEFUSE3 trial dataThrombectomy in Stroke: DAWN and DEFUSE3 trial data
Thrombectomy in Stroke: DAWN and DEFUSE3 trial data
SCGH ED CME
Elma mg out 2 jurnal
Elma mg out 2 jurnalElma mg out 2 jurnal
Elma mg out 2 jurnal
MaharaniElma
Decreased door to balloon time
Decreased door to balloon timeDecreased door to balloon time
Decreased door to balloon time
DrShamshad Khan

Similar to Nccu journal club 2.5.13 (20)

Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18
Anand Tiwari
BTF-Guidelines-for-TBI-Management.pdf
BTF-Guidelines-for-TBI-Management.pdfBTF-Guidelines-for-TBI-Management.pdf
BTF-Guidelines-for-TBI-Management.pdf
TungToManh
Penchalaya (1)
Penchalaya (1)Penchalaya (1)
Penchalaya (1)
Dr Ronak Raheja
Lessons from the TTM trial and planning for the nexst
Lessons from the TTM trial and planning for the nexstLessons from the TTM trial and planning for the nexst
Lessons from the TTM trial and planning for the nexst
scanFOAM
Landmark trials in neuro critical care.pptx
Landmark trials in neuro critical care.pptxLandmark trials in neuro critical care.pptx
Landmark trials in neuro critical care.pptx
isccmhyd
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real WorldBCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
SMACC Conference
Journal club presentation
Journal club presentation Journal club presentation
Journal club presentation
YalewaykerBrhan1
Guidelines for severe traumatic brain injury4
Guidelines for severe traumatic brain injury4Guidelines for severe traumatic brain injury4
Guidelines for severe traumatic brain injury4
uday kumar
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017
Steve Mathieu
Trials in tbi
Trials in tbiTrials in tbi
Trials in tbi
shahamrita8
Stroke thrombolysis
Stroke thrombolysisStroke thrombolysis
Stroke thrombolysis
Iain McNeill
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Premier Publishers
Intensive Insulin Therapy In The Medical Icu
Intensive Insulin Therapy In The Medical IcuIntensive Insulin Therapy In The Medical Icu
Intensive Insulin Therapy In The Medical Icu
NadSamm
Out of hospital hypertonic saline
Out of hospital hypertonic salineOut of hospital hypertonic saline
Out of hospital hypertonic saline
nswhems
SIREN/BOOST3 Overview
SIREN/BOOST3 OverviewSIREN/BOOST3 Overview
SIREN/BOOST3 Overview
University of Michigan Department of Emergency Medicine
Journal Review INTERACT 2
Journal Review INTERACT 2Journal Review INTERACT 2
Journal Review INTERACT 2
NeurologyKota
Cdmjc cole4
Cdmjc cole4Cdmjc cole4
Cdmjc cole4
Shaun0479
Alpheus trial ppt
Alpheus trial pptAlpheus trial ppt
Alpheus trial ppt
Piyush Bhardwaj
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptxEffect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
NayyarSaleem2
Major trials in Head Injury.pptx
Major trials in Head Injury.pptxMajor trials in Head Injury.pptx
Major trials in Head Injury.pptx
Soumen Kanjilal
Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18
Anand Tiwari
BTF-Guidelines-for-TBI-Management.pdf
BTF-Guidelines-for-TBI-Management.pdfBTF-Guidelines-for-TBI-Management.pdf
BTF-Guidelines-for-TBI-Management.pdf
TungToManh
Lessons from the TTM trial and planning for the nexst
Lessons from the TTM trial and planning for the nexstLessons from the TTM trial and planning for the nexst
Lessons from the TTM trial and planning for the nexst
scanFOAM
Landmark trials in neuro critical care.pptx
Landmark trials in neuro critical care.pptxLandmark trials in neuro critical care.pptx
Landmark trials in neuro critical care.pptx
isccmhyd
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real WorldBCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
BCC4: Anthony Delaney on Traumatic Brain Injury in the Real World
SMACC Conference
Journal club presentation
Journal club presentation Journal club presentation
Journal club presentation
YalewaykerBrhan1
Guidelines for severe traumatic brain injury4
Guidelines for severe traumatic brain injury4Guidelines for severe traumatic brain injury4
Guidelines for severe traumatic brain injury4
uday kumar
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017
Steve Mathieu
Trials in tbi
Trials in tbiTrials in tbi
Trials in tbi
shahamrita8
Stroke thrombolysis
Stroke thrombolysisStroke thrombolysis
Stroke thrombolysis
Iain McNeill
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Reperfusion strategy in patients with ST-Segment Elevation Myocardial Infarct...
Premier Publishers
Intensive Insulin Therapy In The Medical Icu
Intensive Insulin Therapy In The Medical IcuIntensive Insulin Therapy In The Medical Icu
Intensive Insulin Therapy In The Medical Icu
NadSamm
Out of hospital hypertonic saline
Out of hospital hypertonic salineOut of hospital hypertonic saline
Out of hospital hypertonic saline
nswhems
Journal Review INTERACT 2
Journal Review INTERACT 2Journal Review INTERACT 2
Journal Review INTERACT 2
NeurologyKota
Cdmjc cole4
Cdmjc cole4Cdmjc cole4
Cdmjc cole4
Shaun0479
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptxEffect Of Remote Ischemic Preconditioning On AKI Among.pptx
Effect Of Remote Ischemic Preconditioning On AKI Among.pptx
NayyarSaleem2
Major trials in Head Injury.pptx
Major trials in Head Injury.pptxMajor trials in Head Injury.pptx
Major trials in Head Injury.pptx
Soumen Kanjilal

Nccu journal club 2.5.13

  • 1. NCCU Journal Club JOSHUA KORNBLUTH, MD F E B 5 TH, 2 0 1 3
  • 2. Objective: to review a recent randomized trial of intracranial pressure monitoring in sTBI To encourage thought and discussion of our own practices To consider future directions Nothing for me to disclose
  • 3. Study Overview Does intracranial pressure monitoring improve outcomes in severe TBI? What is the current standard of care in America? Why does this question matter? Multicenter, 324 adult pts, severe TBI, randomized to two separate protocols Looked at in-hospital events, survival time and 3- and 6- month outcomes
  • 5. You heard it from the BTF
  • 6. Study Overview Can we conduct this type of study in America? Highly unlikely, so let's take advantage of alternative standards of care to investigate. Study Design Multicenter, parallel-group trial Random assignment to ICP-monitoring group vs imaging- clinical examination group Study started in Bolivian hospitals, and additional hospitals were added later to increase enrollment
  • 7. Study Design Inclusion Criteria Traumatic brain injury GCS < 8 on admission or within first 48 hours after injury (Motor score 5 if intubated) Admission to study hospital within 24 hours of injury No foreign object in the brain parenchyma. Age > 12 Randomized: within 24 hours of injury [for patients with GCS < 8 on admission] or within 24 hours of deterioration [patients deteriorating to GCS < 8 within 48 hours of injury Randomization stratified according to site, injury severity score, and age
  • 8. Study Design Exclusion Criteria GCS of 3 with bilateral fixed and dilated pupils No consent Pregnant Prisoner No beds available in ICU No ICP monitor available Non-survivable injury Other (e.g., Pre-injury life expectancy under 1 year) Pre-existing neurological disability that would confound outcome
  • 9. Study Design - protocol Place patient on mechanical ventilation (VM) Place continuous SaPO2 and EtCO2 monitors Insert indwelling urinary catheter to monitor urine output Insert arterial catheter for arterial mean pressure monitoring Insert central venous catheter for infusion of solutions and central venous pressure monitoring. Monitor neurological clinical status each hour Pupils GCS Brain CT To evaluate evolution 48 hours after the admission CT To evaluate evolution 5-7 days after the admission CT p.r.n.
  • 10. Study Design Standards of Critical Care Clearly delineate standard basic Critical Care Head positioning 30尊 Head and neck in neutral position and aligned Avoid hyperthermia (Defined as central temperature > 38 尊 C) Non-drug measures (cooling) Dipirona (Metamizole sodium) Early enteral nutritional support Before 48 hours 25 Kcal/kg weight Pharmacologic prophylactic of post traumatic seizures (Phenytoin (IV or PO)) Load and maintenance dose as is being giving in each hospital Gastric bleeding prophylaxis Ranitidine or Omeprazol Avoid decubitus lesions Deep venous thrombosis prophylaxis Frequent tracheal suctioning with sterile technique to prevent pulmonary infections
  • 11. Study Design ICP group Had parenchymal monitor ASAP (i.e. after randomization and resolution of coagulopathy if present) Position was not specified Treat if ICP20mmHg x 5min If CSF drainage indicated, EVD placed CPP goal 50-70mmHg
  • 12. Study Design Treatments (ICP Group) Treatments based on a Therapeutic Intensity Level If signs of intracranial HTN, clinical or imaging 1 hyperosmolar therapy (mannitol) 5% NaCl only if hypotenisve, hypovolemic, hyponatremic 2 optional mild hyperventilation (pCO2 30-35mmHg) 3 Ventricular drainage if possible*
  • 13. Study Design Definitions (ICP Group) Intracranial Pressure Definitions: Treatable intracranial hypertension: ICP > 20 mmHg for > 5 minutes Treatment failure: ICP not reduced to 20 mmHg within 20 minutes after a treatment intervention is initiated, and Persistent elevation in ICP > 20 mmHg requires increase in therapeutic intensity level
  • 14. Study Design Neuroworsening Neuroworsening = Incd TIL 1. Decrease in the motor GCS > 2 2. New loss of pupil reactivity 3. Interval development of pupil asymmetry of > 2mm 4. New focal motor deficit 5. Herniation syndrome Give mannitol 0.25-1mg/kg to sOSM<320 Hyperventilate to pCO2 25-30 If no response thiopental x 3d Craniectomy for space-occupying lesions
  • 15. Study Design Imaging only Group After optimized sedation and analgesia, hyperventilation and hyperosmotic therapy should be started simultaneously if there is evidence of edema on CT, as indicated as following: 1. Compressed peri-mesencephalic cisterns 2. Midline shift 3. Cortical sulcal compression / effacement Otherwise, same metrics and goals of ICP monitored group Corticosteriods prohibited AEDs for prophylaxis >28d
  • 16. Study Design - Outcomes Primary outcome 21-point composite of survival, duration and level of impaired consciousness, 3- month GOSe and GOAT, 6-month GOSe and neuropsych testing Secondary Outcomes ICU LOS, number of days that patients received at least 1 brain-specific treatment, days of MV, treatment with high-dose barbiturates, decompressive crani
  • 19. Results MVAs accounted for most injuries (51% of randomized pts) 45% of pts were brought in by ambulance Remainder were transferred from other facilities Did not publish pre-hospital demographics or interventions as these we not uniformly recorded
  • 20. Results - Demographics 24% of randomized patients had clinical decline to GCS within eligibility criteria 49% of patients had localizing signs on clinical exam 33% of participants required surgical treatment of mass lesions On initial CT, 85% had cisternal compression and 36% had >5mm midline shift
  • 21. Results Clinical Outomes
  • 22. HR for death at 6mos =1.10, slightly in favor of ICP group
  • 25. Results Subgroup Analysis Hospital LOS was slightly shorter in the ICE group (iqr 12 for ICP, 9 for ICE) No significant differences in MV days, of non-neurologic complications Except ICP-monitored pts had a higher incidence of decubitus ulcers (12%vs 5%, P=0.03) Median time of ICP monitoring was 3.6d Incidence of Neuroworsening after randomization was 25% in the entire study, and was similar in both groups Median interval for brain-specific treatments was longer in ICE group Use of barbiturates was significantly higher in the ICP group (24% vs 13%) HTS and HV were used more in the ICE group (72% vs 58%, 73% vs 60%)
  • 26. Results Almost every variable, including LOS, mortality, anf functional outcomes favored ICP monitoring with a HR>1. The study was powered to detect statistical significance of HR>1.5 Subgroup analysis of HR accounting for Marshall CT Classification
  • 27. Results Summary Composite endpoints between the two groups were similar (P=0.49) ICP group = 56 ICE group = 53 Mortality at 6 months (P=0.06) ICP group=39% ICE group=41% ICE group had more days of brain specific treatments (hyperosmolar therapy, HV)
  • 28. Discussion So what did the trial show? Clinicians act on ICP, without clinical correlate as evidenced by the increased use of barbiturates Clinicians also act on clinical findings without quantitative evidence of intracranial hypertension as evidenced by more brain-specific treatments overall in the ICE group. Is this because increased ICP could herald clinical changes and early interventions abort herniation events? Also, radiographic signs may not translate to the parenchymal monitor.
  • 29. Discussion - Skepticism South America differences in pre-hospital, and post- hospital care Less might survive to hospital or to hospital transfer Rehabilitation standards are different and may not translate to the same cognitive recovery 35%death in all groups after 14d Adjusted estimates of sTBI mortality in the US varies from 41%-25% (J Neurotrauma. 2012 Jan 1;29(1):47-52., J Neurotrauma. 2012 Jan 1;29(1):47-52.) The Thereapeutic Intensity Level is a good overall metric but others such as %responders to ICP-lowering therapy has proven predictive and should have been incorporated (J Neurosurg. 2011 May;114(5):1471-8)
  • 30. Discussion - Skepticism Technology parenchymal monitors as standard Triggers for treatment? ICP>20 x 5 min vs radiographic signs with or without clinical correlates ICP group ICP triggers ICP is too simplistic a reflection of intracranial pathophysiology. No account for CPP Clinical signs dont always reflect global pressures and vice versa No discussion of inclusion/exclusion of polytrauma and surgical interventions
  • 31. Discussion - Skepticism Variability in treatments (i.e. more mannitol and HV in the ICE group) may be because the ICE group had scheduled scans and interventions and the ICP group had more event-related treatment triggers Conversely, that may explain why the ICP group had more barbiturates and HTS
  • 32. Discussion - benefits Very rigorous treatment algorithm for management of elevated ICP (either qualitative or quantitative) Homogenous population across countries Both groups had intracranial HTN treated that isnt in question In truth, this study did not test ICP monitoring, only a very specific treatment algorithm to an ICP threshold compared with clinical exam In the end, the neurologic exam might STILL be the best tool in our disposal.
  • 33. Further Discussion This was probably the only way that this type of trial could be done Authors were careful not to compare South American patients to our own, only report their findings The goal of therapies was to lower the average ICP within the head this doesnt accurately reflect mechanical compression and injury to diepnephalic which may portend a worse prognosis. The clinical signs of elevated ICP (pupil dilations, posturing, coma) are directly related to these areas.
  • 34. Further Discussion How would you alter the study? Could multimodal monitoring be the next step? Are composite endpoints more useful that single variable? i.e. mortality? Return to work? Is a 6-month outcome long enough? Dont forget that even the most rigorous study cannot account for all possible variables and that this data might not apply to every patient.

Editor's Notes

  • #19: No significant differences between the groupsOnly true subjective variable is the signs of intracranial hypertension, which is recorded as the impression as the interpreting physician